Skip to main content

What the FDA labels say about taking them together

Methylergonovine and nevirapine

Methylergonovine's FDA label of May 1, 2026 names nevirapine in its drug interactions section; the nevirapine label PlainMeds reads does not name methylergonovine. The methylergonovine label: “CYP3A4 inducers Drugs that are strong inducers of CYP3A4 are likely to decrease the pharmacological action of methylergonovine maleate.”

Check it at the source: the methylergonovine FDA label on DailyMed (effective May 1, 2026, Teva Pharmaceuticals USA, Inc.); the nevirapine FDA label on DailyMed (effective July 15, 2026, Mylan Pharmaceuticals Inc.).

What does the methylergonovine label say about nevirapine?

Methylergonovine label, drug interactions

CYP3A4 inducers Drugs (e.g. nevirapine, rifampin) that are strong inducers of CYP3A4 are likely to decrease the pharmacological action of methylergonovine maleate.

Source: FDA drug label (Methylergonovine Maleate), Teva Pharmaceuticals USA, Inc., effective May 1, 2026 (SPL set d8e4b8ed-3289-4611-8a61-2392a4bf6072), via openFDA; the full label on DailyMed

What does the nevirapine label say about methylergonovine?

Nevirapine's label (effective July 15, 2026) does not name methylergonovine in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Nevirapine), Mylan Pharmaceuticals Inc., effective July 15, 2026 (SPL set c6e93829-7024-48f6-8023-da6ff27dfc0a), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

14Methylergonovine generic labelers
6Nevirapine generic labelers
MethylergonovineNevirapine
Labeled forn/aHIV
Boxed warningNoYes
Pharmacy cost (NADAC)$4.50 per tablet 0.2 mg tablet$0.147 per tablet 200 mg tablet
Shortage nowNo current entryNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?